These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 31855875

  • 1. Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Leng X, He W, Yang H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Liu H, Yang H, Li T, Zhang X, Li Q, Wang G, Mao T, Guo X, Lin T, Liu M, Fu J, Han Y.
    Ann Surg; 2021 Dec 01; 274(6):e1022-e1029. PubMed ID: 31855875
    [Abstract] [Full Text] [Related]

  • 2. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H, Tang H, Fang Y, Tan L, Yin J, Shen Y, Zeng Z, Zhu J, Hou Y, Du M, Jiao J, Jiang H, Gong L, Li Z, Liu J, Xie D, Li W, Lian C, Zhao Q, Chen C, Zheng B, Liao Y, Li K, Li H, Wu H, Dai L, Chen KN.
    JAMA Surg; 2021 May 01; 156(5):444-451. PubMed ID: 33729467
    [Abstract] [Full Text] [Related]

  • 3. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
    Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Zhang X, Li Q, Wang G, Chen B, Mao T, Kong M, Guo X, Lin T, Liu M, Fu J.
    JAMA Surg; 2021 Aug 01; 156(8):721-729. PubMed ID: 34160577
    [Abstract] [Full Text] [Related]

  • 4. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K.
    Ann Surg Oncol; 2013 Sep 01; 20(9):3038-43. PubMed ID: 23625142
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Hamai Y, Hihara J, Emi M, Furukawa T, Murakami Y, Nishibuchi I, Ibuki Y, Yamakita I, Kurokawa T, Nagata Y, Okada M.
    World J Surg; 2018 May 01; 42(5):1496-1505. PubMed ID: 29030675
    [Abstract] [Full Text] [Related]

  • 6. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.
    Dijksterhuis WPM, Hulshoff JB, van Dullemen HM, Kats-Ugurlu G, Burgerhof JGM, Korteweg T, Mul VEM, Hospers GAP, Plukker JTM.
    Acta Oncol; 2019 Nov 01; 58(11):1640-1647. PubMed ID: 31397195
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Kim JY, Yun JK, Kim YH, Park SI, Lee JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Kim SB, Cho KJ, Ryu JS, Kim JH, Kang J, Park SR, Kim HR.
    Ann Surg Oncol; 2024 Oct 01; 31(10):6662-6672. PubMed ID: 38954089
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
    Zhang G, Zhang C, Sun N, Xue L, Yang Z, Fang L, Zhang Z, Luo Y, Gao S, Xue Q, Mu J, Gao Y, Tan F, He J.
    J Cancer Res Clin Oncol; 2022 Apr 01; 148(4):943-954. PubMed ID: 34013382
    [Abstract] [Full Text] [Related]

  • 9. Clinical Significance of 18F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
    Hamai Y, Hihara J, Emi M, Ibuki Y, Murakami Y, Nishibuchi I, Nagata Y, Aoki Y, Furukawa T, Okada M.
    Ann Surg Oncol; 2019 Jun 01; 26(6):1869-1878. PubMed ID: 30675704
    [Abstract] [Full Text] [Related]

  • 10. Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Wang Y, Ma K, Zhang H, Wu L, Liu L, Zhou Y, Peng L, Wang Q, Zhuang X.
    BMC Cancer; 2024 Oct 05; 24(1):1228. PubMed ID: 39369225
    [Abstract] [Full Text] [Related]

  • 11. Incidence and Predictors of Unsuspected Recurrent Laryngeal Nerve Lymph Node Metastases After Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma.
    Li ZG, Zhang XB, Wen YW, Liu YH, Chao YK.
    World J Surg; 2018 Aug 05; 42(8):2485-2492. PubMed ID: 29380005
    [Abstract] [Full Text] [Related]

  • 12. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved.
    Tang H, Tan L, Wang H, Shen Y, Yin J.
    J Gastrointest Surg; 2020 Jul 05; 24(7):1469-1476. PubMed ID: 31346888
    [Abstract] [Full Text] [Related]

  • 13. Oncologic Outcome of Patients With Pathologic T0 Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Chen SB, Wang X, Chen YP.
    Cancer Control; 2024 Jul 05; 31():10732748241284905. PubMed ID: 39259832
    [Abstract] [Full Text] [Related]

  • 14. Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Huang X, Jiang D, Jian Z, Zeng Z, Zhang S, Fan H, Sun T, Tang H, Hou Y, Tan L.
    Ann Surg Oncol; 2024 Feb 05; 31(2):883-891. PubMed ID: 38038788
    [Abstract] [Full Text] [Related]

  • 15. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
    Depypere L, De Hertogh G, Moons J, Provoost AL, Lerut T, Sagaert X, Coosemans W, Van Veer H, Nafteux P.
    Ann Thorac Surg; 2021 Dec 05; 112(6):1847-1854. PubMed ID: 33352178
    [Abstract] [Full Text] [Related]

  • 16. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E, van Rossum PSN, Ruurda JP, van Hillegersberg R.
    Ann Surg; 2017 Nov 05; 266(5):863-869. PubMed ID: 28742691
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
    Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Lordick F, D'Journo XB, Cerfolio RJ, Korst RJ, Novoa NM, Swanson SJ, Brunelli A, Ismail M, Fernando HC, Zhang X, Li Q, Wang G, Chen B, Mao T, Kong M, Guo X, Lin T, Liu M, Fu J, AME Thoracic Surgery Collaborative Group.
    J Clin Oncol; 2018 Sep 20; 36(27):2796-2803. PubMed ID: 30089078
    [Abstract] [Full Text] [Related]

  • 18. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
    Cho WK, Oh D, Ahn YC, Shim YM, Zo JI, Sun JM, Ahn MJ, Park K.
    Oncotarget; 2017 Jan 10; 8(2):3542-3552. PubMed ID: 27682879
    [Abstract] [Full Text] [Related]

  • 19. Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Guo X, Wang Z, Yang H, Mao T, Chen Y, Zhu C, Yu Z, Han Y, Mao W, Xiang J, Chen Z, Liu H, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Zhang X, Li Q, Wang G, Lin T, Liu M, Fu J, Fang W.
    Ann Surg; 2023 Feb 01; 277(2):259-266. PubMed ID: 33605586
    [Abstract] [Full Text] [Related]

  • 20. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma.
    Hsu PK, Chen HS, Liu CC, Wu SC.
    Ann Surg Oncol; 2019 Feb 01; 26(2):506-513. PubMed ID: 30430325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.